1,3,5-trisubstituted triazole derivative

Details for Australian Patent Application No. 2008313775 (hide)

Owner Janssen Pharmaceutica NV

Inventors Thuring, Johannes Wilhelmus John F.; Dinklo, Theodorus; Lesage, Anne Simone Josephine

Agent Shelston IP

Pub. Number AU-A-2008313775

PCT Pub. Number WO2009/050185

Priority 07118822.1 18.10.07 EP

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/050185 Priority application(s): WO2009/050185

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008313776-Trisubstituted 1,2,4-triazoles

2008313773-Imidazo [1, 2-A] pyridine derivatives useful as ALK inhibitors